廣信材料(300537.SZ):2024年上半年PCB光刻膠佔公司整體收入52.56%,光伏膠佔公司整體收入13.06%
格隆匯12月2日丨廣信材料(300537.SZ)在投資者互動平台表示,公司光刻膠及配套材料板塊發展戰略以PCB光刻膠為基本盤、適度開拓顯示半導體光刻膠、重點突破光伏BC電池絕緣膠等光伏新技術核心增量光伏膠。PCB光刻膠板塊一直是公司創辦以來發展的基石,PCB阻焊油墨、PCB 濕膜光刻膠(PCB線路油墨)等PCB光刻膠是公司主營業務產品,2024年上半年PCB光刻膠佔公司整體收入52.56%,光伏膠佔公司整體收入13.06%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.